CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset

Affiliations

• ¹ Department of Internal Medicine, Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University of Mainz, Mainz, Germany.
• ² Fellowship Programme Unit, EORTC Headquarters, Brussels, Belgium.
• ³ Statistics Department, EORTC Headquarters, Brussels, Belgium.
• ⁴ Molekulare/Prädiktive Diagnostik, Koordination UCC Tumor- und Normalgewebebank Institut für Pathologie, Dresden, Germany.
• ⁵ Caritas Klinikum Saarbrücken, Saarbrücken, Germany.
• ⁶ Evangel. Bethesda-Krankenhaus, Essen, Germany.
• ⁷ Klinikum der JW Goethe, Universität Frankfurt am Main, Frankfurt, Germany.
• ⁸ Department of Oncology and Hematology, Klinikum Oldenburg, European Medical School Oldenburg/Groningen, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.
• ⁹ Second Department of Gastroenterology, Hygeia Hospital, Athens, Greece.